These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 25936906)

  • 21. Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD.
    Belalcazar LM; Papandonatos GD; Erar B; Peter I; Alkofide H; Balasubramanyam A; Brautbar A; Kahn SE; Knowler WC; Ballantyne CM; McCaffery JM; Huggins GS;
    Circ Cardiovasc Genet; 2016 Feb; 9(1):71-8. PubMed ID: 26578543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fiber intake and plasminogen activator inhibitor-1 in type 2 diabetes: Look AHEAD (Action for Health in Diabetes) trial findings at baseline and year 1.
    Belalcazar LM; Anderson AM; Lang W; Schwenke DC; Haffner SM; Yatsuya H; Rushing J; Vitolins MZ; Reeves R; Pi-Sunyer FX; Tracy RP; Ballantyne CM;
    J Acad Nutr Diet; 2014 Nov; 114(11):1800-10.e2. PubMed ID: 25131348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial.
    Taheri S; Chagoury O; Zaghloul H; Elhadad S; Ahmed SH; Omar O; Payra S; Ahmed S; El Khatib N; Amona RA; El Nahas K; Bolton M; Chaar H; Suleiman N; Jayyousi A; Zirie M; Janahi I; Elhag W; Alnaama A; Zainel A; Hassan D; Cable T; Charlson M; Wells M; Al-Hamaq A; Al-Abdulla S; Abou-Samra AB
    Trials; 2018 May; 19(1):284. PubMed ID: 29784059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Association of GLUL rs10911021 With Cardiovascular Morbidity and Mortality Among Individuals With Type 2 Diabetes: The Look AHEAD Study.
    Look AHEAD Research Group
    Diabetes; 2016 Jan; 65(1):297-302. PubMed ID: 26395743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can an intensive diet and exercise program prevent knee pain among overweight adults at high risk?
    White DK; Neogi T; Rejeski WJ; Walkup MP; Lewis CE; Nevitt MC; Foy CG; Felson DT;
    Arthritis Care Res (Hoboken); 2015 Jul; 67(7):965-71. PubMed ID: 25692781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four-year change in cardiorespiratory fitness and influence on glycemic control in adults with type 2 diabetes in a randomized trial: the Look AHEAD Trial.
    Jakicic JM; Egan CM; Fabricatore AN; Gaussoin SA; Glasser SP; Hesson LA; Knowler WC; Lang W; Regensteiner JG; Ribisl PM; Ryan DH;
    Diabetes Care; 2013 May; 36(5):1297-303. PubMed ID: 23223405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.
    Look AHEAD Research Group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):801-9. PubMed ID: 25127483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.
    Ryan DH; Espeland MA; Foster GD; Haffner SM; Hubbard VS; Johnson KC; Kahn SE; Knowler WC; Yanovski SZ;
    Control Clin Trials; 2003 Oct; 24(5):610-28. PubMed ID: 14500058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of BMI with cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus: A systematic review and dose-response meta-analysis of cohort studies.
    Zhao Y; Qie R; Han M; Huang S; Wu X; Zhang Y; Feng Y; Yang X; Li Y; Wu Y; Liu D; Hu F; Zhang M; Sun L; Hu D
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):1976-1984. PubMed ID: 33965298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study.
    Belalcazar LM; Reboussin DM; Haffner SM; Hoogeveen RC; Kriska AM; Schwenke DC; Tracy RP; Pi-Sunyer FX; Ballantyne CM;
    Diabetes Care; 2010 Nov; 33(11):2297-303. PubMed ID: 20682679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials.
    Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K
    Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of weight management in type 2 diabetes mellitus.
    Wilding JP
    Int J Clin Pract; 2014 Jun; 68(6):682-91. PubMed ID: 24548654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of electronic medical records for recruitment in clinical trials: findings from the Lifestyle Intervention for Treatment of Diabetes trial.
    Effoe VS; Katula JA; Kirk JK; Pedley CF; Bollhalter LY; Brown WM; Savoca MR; Jones ST; Baek J; Bertoni AG;
    Trials; 2016 Oct; 17(1):496. PubMed ID: 27733193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Lifestyle Intervention With Risk for Cardiovascular Events Differs by Level of Glycated Hemoglobin.
    Bancks MP; Pilla SJ; Balasubramanyam A; Yeh HC; Johnson KC; Rigdon J; Wagenknecht LE; Espeland MA
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1012-e1019. PubMed ID: 37978826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in adipose tissue depots and metabolic markers following a 1-year diet and exercise intervention in overweight and obese patients with type 2 diabetes.
    Gallagher D; Heshka S; Kelley DE; Thornton J; Boxt L; Pi-Sunyer FX; Patricio J; Mancino J; Clark JM;
    Diabetes Care; 2014 Dec; 37(12):3325-32. PubMed ID: 25336745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of lifestyle change for prevention of cardiovascular disease in diabetes.
    Staimez LR; Weber MB; Gregg EW
    Curr Atheroscler Rep; 2014 Dec; 16(12):460. PubMed ID: 25363453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of an intensive lifestyle intervention with remission of type 2 diabetes.
    Gregg EW; Chen H; Wagenknecht LE; Clark JM; Delahanty LM; Bantle J; Pownall HJ; Johnson KC; Safford MM; Kitabchi AE; Pi-Sunyer FX; Wing RR; Bertoni AG;
    JAMA; 2012 Dec; 308(23):2489-96. PubMed ID: 23288372
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.